GlassScriptPhysician profile
Emily Taylor Perkins
NPI 1518983444
$1,354.65
in general payments reported to CMS, 2019-2025
22 companies · $132 in 2025
The $132 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $349 · 2020: $195 · 2021: $171 · 2022: $212 · 2023: $73.63 · 2024: $221 · 2025: $132.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $427.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $426.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $203.50 | 2019-2024 | Jornay Pm |
| Merck Sharp & Dohme LLC | $141.45 | 2019-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Pfizer INC. | $130.16 | 2019-2024 | |
| Cranial Technologies, INC | $103.79 | 2019-2025 | Doc Band |
| Sanofi-Aventis U.S. LLC | $95.86 | 2024-2025 | |
| Supernus Pharmaceuticals, INC. | $93.35 | 2021-2024 | Qelbree |
| Sobi, INC | $76.32 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $65.83 | 2019-2021 | |
| Tris Pharma INC | $60.19 | 2019 | |
| Alk-Abello, INC | $57.94 | 2021-2025 | Neffy, Odactra, Grastek |
| Glaxosmithkline, LLC. | $53.38 | 2019-2024 | Bexsero |
| Astrazeneca Pharmaceuticals LP | $51.60 | 2022-2024 | Flumist Quadrivalent |
| Genentech USA, INC. | $35.52 | 2020-2021 | |
| Qol Medical, LLC | $34.45 | 2021 | |
| Phadia US INC. | $27.53 | 2019-2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neos Therapeutics, LP | $21.19 | 2019 | |
| Shire North American Group INC | $19.82 | 2019 | |
| Pbg Puerto Rico LLC | $18.19 | 2021 | |
| Vertical Pharmaceuticals, LLC | $16.74 | 2019 | |
| Galderma Laboratories, L.P. | $16.45 | 2021 | |
| Kaleo, INC. | $16.26 | 2019 | |
| Hologic Sales and Service, LLC | $15.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Perkins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.